Literature DB >> 9058738

Congenital polycythemia in Chuvashia.

A Sergeyeva1, V R Gordeuk, Y N Tokarev, L Sokol, J F Prchal, J T Prchal.   

Abstract

Familial and congenital polycythemia, not due to high oxygen affinity hemoglobin or reduced 2,3-diphosphoglycerate in erythrocytes, is common in the Chuvash population of the Russian Federation. Hundreds of individuals appear to be affected in an autosomal recessive pattern. We studied six polycythemic Chuvash patients <20 years of age from unrelated families and 12 first-degree family members. Hemoglobins were markedly elevated in the index subjects (mean +/- standard deviation [SD] of 22.6 +/- 1.4 g/dL), while platelet and white blood cell counts were normal. Although performed in only three of the index subjects, serum erythropoietin concentrations determined by both radioimmune and functional assays were significantly higher in polycythemic patients compared with first-degree family members with normal hemoglobin concentrations. Southern blot analysis of the Bgl 2 erythropoietin gene polymorphism showed that one polycythemic subject was a heterozygote, suggesting the absence of linkage of polycythemia with the erythropoietin gene, assuming autosomal recessive inheritance. Polymerase chain reaction (PCR) amplification of the GGAA and GA minisatellite polymorphic regions of the erythropoietin receptor gene showed no evidence of linkage of phenotype with this gene. We conclude that Chuvash polycythemia may represent a secondary form of familial and congenital polycythemia of as yet unknown etiology. This condition is the only endemic form of familial and congenital polycythemia described.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9058738

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  26 in total

1.  Natural selection on EPAS1 (HIF2alpha) associated with low hemoglobin concentration in Tibetan highlanders.

Authors:  Cynthia M Beall; Gianpiero L Cavalleri; Libin Deng; Robert C Elston; Yang Gao; Jo Knight; Chaohua Li; Jiang Chuan Li; Yu Liang; Mark McCormack; Hugh E Montgomery; Hao Pan; Peter A Robbins; Kevin V Shianna; Siu Cheung Tam; Ngodrop Tsering; Krishna R Veeramah; Wei Wang; Puchung Wangdui; Michael E Weale; Yaomin Xu; Zhe Xu; Ling Yang; M Justin Zaman; Changqing Zeng; Li Zhang; Xianglong Zhang; Pingcuo Zhaxi; Yong Tang Zheng
Journal:  Proc Natl Acad Sci U S A       Date:  2010-06-07       Impact factor: 11.205

2.  Inherited predisposition to myeloproliferative neoplasms.

Authors:  Amy V Jones; Nicholas C P Cross
Journal:  Ther Adv Hematol       Date:  2013-08

3.  Oxygen sensing: recent insights from idiopathic erythrocytosis.

Authors:  Frank S Lee; Melanie J Percy; Mary Frances McMullin
Journal:  Cell Cycle       Date:  2006-05-01       Impact factor: 4.534

Review 4.  From gene engineering to gene modulation and manipulation: can we prevent or detect gene doping in sports?

Authors:  Giuseppe Fischetto; Stéphane Bermon
Journal:  Sports Med       Date:  2013-10       Impact factor: 11.136

5.  Regulation of human metabolism by hypoxia-inducible factor.

Authors:  Federico Formenti; Dumitru Constantin-Teodosiu; Yaso Emmanuel; Jane Cheeseman; Keith L Dorrington; Lindsay M Edwards; Sandy M Humphreys; Terence R J Lappin; Mary F McMullin; Christopher J McNamara; Wendy Mills; John A Murphy; David F O'Connor; Melanie J Percy; Peter J Ratcliffe; Thomas G Smith; Marilyn Treacy; Keith N Frayn; Paul L Greenhaff; Fredrik Karpe; Kieran Clarke; Peter A Robbins
Journal:  Proc Natl Acad Sci U S A       Date:  2010-06-28       Impact factor: 11.205

Review 6.  The HIF and other quandaries in VHL disease.

Authors:  D Tarade; M Ohh
Journal:  Oncogene       Date:  2017-09-18       Impact factor: 9.867

7.  von Hippel-Lindau mutation in mice recapitulates Chuvash polycythemia via hypoxia-inducible factor-2alpha signaling and splenic erythropoiesis.

Authors:  Michele M Hickey; Jennifer C Lam; Natalie A Bezman; W Kimryn Rathmell; M Celeste Simon
Journal:  J Clin Invest       Date:  2007-12       Impact factor: 14.808

Review 8.  Erythropoietin.

Authors:  H Franklin Bunn
Journal:  Cold Spring Harb Perspect Med       Date:  2013-03-01       Impact factor: 6.915

9.  Mutations of von Hippel-Lindau tumor-suppressor gene and congenital polycythemia.

Authors:  Yves Pastore; Katerina Jedlickova; Yongli Guan; Enli Liu; James Fahner; Henrik Hasle; Jaroslav F Prchal; Josef T Prchal
Journal:  Am J Hum Genet       Date:  2003-07-03       Impact factor: 11.025

Review 10.  Molecular basis of polycythemic disorders due to aberrant hypoxia sensing and its relevance to acute leukemia.

Authors:  Josef T Prchal
Journal:  Best Pract Res Clin Haematol       Date:  2012-10-25       Impact factor: 3.020

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.